In reply: Comment on: Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study

Jun 13, 2024Canadian journal of anaesthesia = Journal canadien d'anesthesie

Link between diabetes drug use and stomach contents in fasting patients having anesthetized endoscopy

AI simplified

GLP-1 TherapiesGLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Full Text

Full text is available at the source.
View full text (PDF) ↗View full text (HTML) ↗

Related papers

Jun '24
Glucagon-like peptide-1 treatment linked to food in the stomach of fasting patients during sedated endoscopy
top 20% journal
cited by 2 papers
comment
Mar '24
Link between glucagon-like peptide-1 receptor treatment and stomach contents in fasting patients having sedated endoscopy
top 20% journal
cited by 53 papers
journal article
Feb '25
Use of diabetes drugs during surgery and leftover stomach contents in patients having planned upper digestive exams
top 10% journal
cited by 3 papers
journal article
Apr '25
Link between using glucagon-like peptide-1 receptor drugs and lung aspiration during surgery: a systematic review and analysis
top 5% journal
cited by 18 papers
systematic review
Jan '25
Effects of diabetes drugs on anesthesia and procedure outcomes in patients having outpatient upper digestive tract exams
top 5% journal
cited by 7 papers
journal article
Mar '24
Use of Glucagon-Like Peptide-1 Drugs and Remaining Stomach Contents Before Anesthesia
top 2% journal
cited by 152 papers
journal article
Mar '25
Glucagon-like peptide-1 receptor drugs may raise the risk of leftover stomach contents and lung aspiration during upper endoscopy
top 20% journal
cited by 3 papers
meta-analysis
Aug '24
Is it necessary to stop diabetes drugs that activate glucagon-like peptide-1 receptors before an endoscopy? A look back at past cases
top 10% journal
cited by 18 papers
journal article
Oct '24
Use of Glucagon-like Peptide-1 Drugs Before Upper Stomach and Throat Exams and the Risk of Breathing Problems or Stopping the Procedure
top 5% journal
cited by 44 papers
journal article
Dec '24
Use of glucagon-like peptide-1 receptor drugs and the risk of leftover stomach contents and choking during digestive system exams
top 5% journal
cited by 29 papers
systematic review

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #31
Semaglutide linked to 54% lower risk of new sleep apnea cases in 1.25 million patients
4 days ago7 studies
issue #30
Tirzepatide beats semaglutide for heart protection in 70,672 non-diabetic adults with obesity
1 week ago7 studies
issue #29
Stopping GLP-1 drugs before endoscopy cuts stomach content risk from 25% to 3%
2 weeks ago7 studies
issue #28
Semaglutide linked to 74-fold higher risk of vision-threatening eye condition
3 weeks ago3 studies
issue #27
GLP-1 drugs linked to 18% lower risk of substance use disorders in 524,817 veterans
4 weeks ago7 studies
issue #26
86.5% of patients on semaglutide or tirzepatide lost at least 5% of body weight at 6 months in Medicaid study
5 weeks ago7 studies
issue #25
GLP-1 drugs linked to 20% lower dementia risk in diabetic kidney patients
6 weeks ago7 studies
issue #24
Tirzepatide beats semaglutide for weight loss by 6.1% in head-to-head comparison
7 weeks ago7 studies
issue #23
Bariatric Surgery vs. GLP-1s for cardiovascular risk
8 weeks ago7 studies
issue #22
GLP-1 drugs linked to better pregnancy rates in PCOS women and reduced cancer risk in diabetes patients
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief